A Welcome Message
Welcome to the Georgetown University Medical Center! As the Dean for Research, I’d like to tell you about some of the amazing things happening here.
You’re probably already familiar with some of the Medical Center’s successes, even if you didn’t know they were developed here. These include Allegra and Gardisil- all researched and developed within our laboratories. We’re also engaged in the first broad clinical trial testing ways to use gene therapy to slow the progress of Parkinson’s disease as well as clinical trials for potential cures for Alzheimer’s disease.
Georgetown is a leading research university with over 80% of sponsored research funding at the Medical Center. And despite the funding cuts you may be hearing about, we still have a good success rate for grant applications submitted to NIH, well within our historical success rate.
We are known for our leadership in Health Sciences education and our research enterprise focuses on collaborative, interdisciplinary research.
We are also known for excellent graduate education programs, including doctorate and master’s degrees in many disciplines. To learn more about these programs, visit the websites of Biomedical Graduate Education, the School of Medicine, and the School of Nursing and Health Sciences.
Georgetown University Medical Center is one of a handful of academic medical centers across the country who can boast both a Center for Clinical and Translational Science as well as a Comprehensive Cancer center with a prestigious Cancer Center Support Grant (CCSG).
The highlights I’ve mentioned are just a few of the reasons why Georgetown is an exciting academic medical center. As a breast cancer researcher, I am surrounding by students and colleagues who constantly see the power and promise in the work we do. I encourage you to spend some time on our website and to visit us on the hilltop soon.
Robert Clarke, Ph.D., D.Sc. is an internationally recognized leader in breast cancer research. Dr. Clarke's research interests include understanding the cellular and molecular mechanisms driving endocrine resistance in breast cancer. He also is interested in drug resistance (cytotoxic, endocrine, chemopreventive agents), drug/hormone interactions, and the application of molecular profiling (e.g., transcriptomics, genomics, metabolomics, and tissue arrays) to predict breast cancer phenotypes and identify functionally relevant gene signaling networks. Dr. Clarke leads several multinational molecular medicine studies in breast cancer, in collaboration with colleagues at Lombardi Comprehensive Cancer Center, Virginia Tech and the University of Edinburgh. Currently he leads a NCI-funded Center for Cancer Systems Biology at Georgetown University Medical Center. Dr. Clarke has served as chair of several NIH peer-review study sections, and he currently serves as a Senior Editor for the journal Cancer Research, as an Associate Editor for Endocrine-Related Cancer, and he is a member of the editorial boards of over a dozen other international peer review journals including Clinical Cancer Research, Molecular Cancer Therapeutics and the British Journal of Cancer. He is a Fellow of the Royal Society of Chemistry, a Fellow of the Royal Society of Medicine, and a Fellow of the Society of Biology in the U.K. Dr. Clarke is the Dean for Research at Georgetown University Medical Center, home to over 80% of the sponsored research at Georgetown University and co-Director of the Breast Cancer Program at the Georgetown-Lombardi Comprehensive Cancer Center.
To learn more about Dr. Clarke's research, please visit his faculty profile.